BlueCity Holdings Clocks 18% Revenue Growth In Q2

BlueCity Holdings Ltd (NASDAQ: BLCT) reported second-quarter FY21 revenue growth of 18% year-on-year, to RMB291.9 million ($45.2 million).
  • BlueCity Holdings Ltd (NASDAQ:BLCT) reported second-quarter FY21 revenue growth of 18% year-on-year, to RMB291.9 million ($45.2 million).
  • Revenues from Live streaming services improved 6.1% Y/Y to RMB223.0 million ($34.5 million), Membership services rose 113% to RMB33.7 million ($5.2 million), and Advertising services climbed 67.7% to RMB18.0 million ($2.8 million).
  • Monthly active users (MAUs) of BlueCity’s portfolio apps increased 29.3% Y/Y to 8.3 million, while total paying users rose 58.1% Y/Y to 0.724 million.
  • The operating loss expanded to RMB(36.2) million ($(5.6) million). Adjusted Net Loss widened to RMB(38.4) million ($(5.9) million).
  • BlueCity held RMB453.7 million ($70.3 million) in cash and equivalents as of June 30, 2021.
  • Outlook: BlueCity sees FY21 revenue of RMB1.15 billion – RMB1.20 billion.
  • Price Action: BLCT shares are trading higher by 1.13% at $4.46 on the last check Tuesday.
Total
0
Shares
Related Posts
Read More

Aclaris Therapeutics Announces Key Leadership Transitions; Douglas Manion, M.D. Appointed To Succeed Dr. Walker As CEO And Appointed To The Board Of Directors; Kevin Balthaser Appointed CFO To Succeed Retiring Frank Ruffo

- Dr. Neal Walker to transition to Chair of the Board of Directors   - Current Board Chair Christopher Molineaux to become Lead Independent Director - Douglas Manion, M.D. appointed to succeed Dr. Walker as Chief

ACRS